Paper39641
Is there a limbic system equivalent of tardive dyskinesia?
Davis KL and 1 other. Biol Psychiatry, 1979. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Is there a limbic system equivalent of tardive dyskinesia? Papers, record 39641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dyskinesia, Drug-Induced | Major topic |
| Limbic System | Major topic |
| Animals | |
| Antipsychotic Agents | |
| Dose-Response Relationship, Drug | |
| Fluphenazine | |
| Humans | |
| Mesencephalon | |
| Neural Pathways | |
| Receptors, Dopamine | |
| Schizophrenia |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42397413 | Dopamine supersensitivity psychosis: a critical evaluation of diagnostic validators. | J Neural Transm (Vienna) | 2026 | https://conductscience.org/library/papers/42397413 | PubMed |
| 36760795 | Enhancement of adenosine A2A signaling improves dopamine D2 receptor antagonist-induced dyskinesia via β-arrestin signaling. | Front Neurosci | 2022 | https://conductscience.org/library/papers/36760795 | PubMed |
| 23821039 | Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations. | CNS Drugs | 2013 | https://conductscience.org/library/papers/23821039 | PubMed |
| 22249643 | Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone. | Eur Child Adolesc Psychiatry | 2012 | https://conductscience.org/library/papers/22249643 | PubMed |
| 21402722 | Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis. | Schizophr Bull | 2012 | https://conductscience.org/library/papers/21402722 | PubMed |
| 8935814 | Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine. | Psychopharmacology (Berl) | 1996 | https://conductscience.org/library/papers/8935814 | PubMed |
| 6784143 | Increased mesolimbic dopamine binding following chronic haloperidol treatment. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6784143 | PubMed |
| 2292234 | Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia. | Drugs | 1990 | https://conductscience.org/library/papers/2292234 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39641
GET https://conductscience.org/api/papers/v1/39641/authors